Jeffrey Dayno
2020
In 2020, Jeffrey Dayno earned a total compensation of $2.7M as Chief Medical Officer at Harmony Biosciences Holdings, a 302% increase compared to previous year.
Compensation breakdown
| Bonus | $301,972 |
|---|---|
| Option Awards | $1,968,249 |
| Salary | $431,388 |
| Other | $885 |
| Total | $2,702,494 |
Dayno received $2M in option awards, accounting for 73% of the total pay in 2020.
Dayno also received $302K in bonus, $431.4K in salary and $885 in other compensation.
Rankings
In 2020, Jeffrey Dayno's compensation ranked 4,248th out of 13,090 executives tracked by ExecPay. In other words, Dayno earned more than 67.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,248 out of 13,090 | 68th |
Division Manufacturing | 1,715 out of 5,621 | 70th |
Major group Chemicals And Allied Products | 665 out of 2,254 | 71st |
Industry group Drugs | 568 out of 1,954 | 71st |
Industry Pharmaceutical Preparations | 434 out of 1,459 | 70th |
Source: SEC filing on April 9, 2021.
Dayno's colleagues
We found two more compensation records of executives who worked with Jeffrey Dayno at Harmony Biosciences Holdings in 2020.